Keynotes

    • Keynotes
    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
    • Market Access
    • RWE
    • Keynotes
    • Patient Value
Fireside chat: Forget Empowerment: Patients as Partners in Innovation, Education and More
  • How the smartest companies are able to go beyond empowerment, beyond advocacy and work with patients for sustained access in a virtuous circle
  • Why your goal must be to have the most comprehensive patient insights if you are ever going to gain trusted partner status

Percival Barretto-Ko, President, US, Astellas

Marc Boutin, President, National Health Council

    • Keynotes
    • Digital & Customer Experience
    • Patient Value
Pharma Stays Essential In The Era of Digital Care 
  • Digital care can cut costs, improve outcomes and transform the patient experience 
  • No one can go it alone: why digital health depends on Pharma & tech symbiosis
  • How Novo Nordisk’s non-exclusive approach to data sharing leads to patient benefit

Anders Dyhr Toft, Corporate VP, Commercial Innovation (Digital Health, Patient Support Programmes and Devices), Novo Nordisk

    • Keynotes
Transforming Disease Care to Health Care
  • Science and business have aligned to make disease interception a new frontier
  • Why Janssen is advancing its World Without Disease Strategy to spark change now
  • A partner-driven innovation model to predict and preempt disease

Ben Wiegand, PhD., Global Head, World Without Disease Accelerator, Janssen Research & Development, LLC

    • Keynotes
Panel: Unite Patients, Providers and Payers to Bring Preventative Care to Life
  • Preventative care changes lives: how we can transform patient health care experience
  • Go beyond unmet needs to address individual’s pre-disease
  • Align stakeholders to create the market for prevention, interception and cure solutions

Ben Wiegand, PhD., Global Head, World Without Disease Accelerator, Janssen Research & Development, LLC

Panellists TBC

    • Keynotes
    • Digital & Customer Experience
    • Patient Value
    • Market Access
    • RWE
Partner Your Way to a Real Solution
  • What’s your partnership & acquisition strategy? How to identify the organisations that will take your offerings to a completely different level
  • How to combine digital, digital therapeutic, devices and service into a single unit, designed around the ultimate customer.

Michelle Carnahan, Head of North America Diabetes & Cardiovascular and Interim Head of North America General Medicines & Established Products, Sanofi

    • Keynotes
    • Patient Value
Panel: Patient Partnerships Are the Only Path to Value-Based Care. so How Can We Make Them Work?Why patient groups will become pharma's essential link to value beyond the pill
  • Perfect Match: learn what pharma and patient groups both require for partnerships to succeed
  • How National Kidney Foundation worked with 25+ pharma partners to translate advocacy into FDA change

Anthony Gucciardo, SVP, Strategic Partnerships, National Kidney Foundation

Tom Croce, VP, Global Advocacy Relations, Amgen

Scott Williams, VP, Head of Global Patient Advocacy and Strategic Partnerships, EMD Serono

    • Keynotes
    • Commercial Excellence
    • RWE
Let the health entrepreneurs show you how
  • Witness elevator pitches from 6 hand-selected healthcare startups who promise to disrupt pharma – and who could be your next partner
  • Understand the true risk, ambition and what is possible with minimal resource. Confirmed speakers include Adhere Tech, Clara Health and Fit4D
    • Keynotes
    • Patient Value
Walking the talk: The Patient Panel

We talk all the time about introducing the patient's perspective, which is why we are doing that very thing at eyeforpharma Philadelphia. Each stage will have panel of patients who will be sharing their perspectives throughout the conference

Pharma's true north

    • Commercial Excellence
    • Medical Affairs
    • Medical Affairs
Now or never: It’s time for medical leadership
  • Seize the initiative and lead the cross-functional effort to present pharma’s authentic face and deliver real value
  • Use this window of opportunity to establish medical’s strategic position in your company
  • How medical can own the response to value-based customer decisions
  • Shape your medical function as a future model for your company, based on scientific authenticity and patient importance
    • Medical Affairs
Great responsibility, greater capabilities: Build the medical function that takes your strategic importance to the next level
  • Convert doctor’s patient-centric initiatives into tools for value creation within your organization
  • Translate the science when satisfying payer demands for knowledge
    • Medical Affairs
Create a stronger scientific narrative through early engagement of medical affairs in development
  • How medical can bring HCP and stakeholder insights into the clinical-regulatory development process to protect value arguments
  • Why medical writes the best storyline - but requires translation in order to resonate best with customers

Lauren Millette, Director Medical Alignment, AstraZeneca

    • Commercial Excellence
    • Medical Affairs
Tomorrow’s MSL, today. How technology and new attitudes will make the MSL the only F2F representative
  • See why commercial field roles will be redundant in future payer discussions that require a deeper level of understanding.
  • Develop the skills necessary for Medical to be the only F2F representative and provide more ROI than the current model

Robert Cuddihy, Vice President U. S. Medical Affairs, Amgen

    • Medical Affairs
Different country, same objectives. See how medical teams in different geographies can learn from each other
  • Look past the intricacies of each reimbursement model to see how your medical team can take findings from one another
  • How central functions can support regional and local nuances whilst staying true to the science and insights

Victoria Ho, WW Field Medical & Communications Lead, Bristol Myers-Squibb

Stakeholder engagement

    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • Market Access
    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • Market Access
Panel: Speak the language of your consumer to increase engagement
  • Use technology and new information channels to better engage with patients and achieve your patient-centric goals
  • Share information the way consumers want to receive their information in today’s world
  • Use Medical’s role as the scientific face of the company to impart knowledge impartially and become the trusted knowledge source

Moderator: Jimmie Overton, Associate Vice President Global Medical Scientific Information and Library, Allergan

Michele Sharp, Senior Director, Regulatory Affairs, Eli Lilly

Additional panellists TBC

    • Medical Affairs
From abstract to reality: how medical makes patient centricity tangible
  • Establish what is really meant by ‘unmet needs’ and incorporate it into your value story
  • Provide actionable patient insights through better working relationships between medical affairs and patient groups

Speaker TBC

    • Medical Affairs
Focus on creating not demonstrating MSL value
  • Focus your team on creating value for stakeholders and let the results speak for themselves
  • Position your MSL team as the go-to source for scientific knowledge and develop relationships that provide quality insight

Robin Winter-Sperry, Head, Global Field Based Medical Excellence & Insights, Sanofi

Collaboration is key

    • Patient Value
    • Market Access
    • Market Access
Develop a risk-sharing model for future reimbursement decisions
  • Share risk across different stakeholders to create a truly aligned healthcare system
  • Understand the shift in risk from payers to providers and why pharma needs to engage with providers more than ever before

Speaker TBC

Blueprint for the future

    • Patient Value
    • Market Access
    • Patient Value
    • Market Access
Panel: Affordability – The new buzzword for Market Access
  • Create mindset shifts within your access team to focus on affordability
  • Promote affordability through the integration of evidence that will shape policy

Muna Bhanji, SVP, Senior Vice President, Global Market Access & Policy, Merck

Robert Dubois, Executive Vice President and Chief Science Officer, National Pharmaceutical Council

Jenny McNair, Senior Medical Director, Aetna

    • Patient Value
    • Market Access
Patient engagement, a new paradigm for FDA Approval
  • See how patient engagement enhances your product approval
  • Determine the value of PRO endpoints in FDA approval

Speakers from the FDA TBC

    • Market Access
Develop a system to reimburse CAR-T therapies
  • Develop products with the payer-relevant endpoints in mind to build a platform for reimbursement discussions
  • Offset uncertainty with innovative contracting options, and share the risk with payers for your new products

Speaker TBC

    • Market Access
PANEL: Are PBMs part of the problem or the solution for drug pricing issues
  • Evaluate the role of PBMs and whether they add value or cost to your product
  • Imagine a more efficient system for reimbursement and pricing that puts patient needs first

Speaker TBC

The era of data enlightenment

    • Market Access
    • RWE
    • RWE
From validation to discovery. The next step for Real-World Evidence
  • See a future where RWE is used to explore new fields of medicine rather than gap-filling value stories using genomic markets
  • Realize the potential of big data

Speaker TBC

    • Market Access
    • RWE
How to establish an effective RWE strategy across your product lifecycle
  • Involve R&D colleagues from Phase II onwards to incorporate endpoints that align with RWE goals
  • Choose the appropriate data sources and methodological approaches to structure and analyze data to produce viable action plans

Speaker TBC

    • RWE
Reduce data silos to unleash the potential of big data
  • Determine a standard of how we truly allocate value to data
  • Develop a blueprint to drive data collection forward but reduce data silos
  • Overcome regulatory and policy hurdles to enable true data sharing for the good of research and ultimately patients

Speaker TBC

    • RWE
It's not all about size: from big data to ‘the right data’
  • Develop a deep understanding to understand the strengths and weaknesses of each data set
  • Choose the right data for the right question for the most robust answer possible

Speaker TBC

    • RWE
Boost clinical trial enrolment with clinical trial matching
  • Use a patient’s data to find the most suitable clinical trial for each patient
  • Work with clinicians to increase trial numbers and seed up the approval process

Speaker TBC

    • RWE
Unlock the value of Real-World Data for internal and external stakeholders
  • Incorporate RWD into the plan for your asset with cross-functional support from your internal stakeholders
  • Prove the value of your data when crafting your commercial value message
  • Show physicians and payers how your product has performed through effective RWD analysis

Speaker TBC

Quality Control

    • Patient Value
    • Medical Affairs
    • RWE
    • Patient Value
    • Medical Affairs
    • RWE
RWD is the patient’s experience! How medical can direct more patient-focused internal policy
  • Use data insights to construct a more complete picture of the patient journey and establish better metrics that uphold value
  • Generate quality patient insights and action them to live up to your patient-centric promise

Speaker TBC

    • Patient Value
    • RWE
Put the patient in charge of their own data to analyze EHRs in their purest form
  • Work with patients to use their data without losing key value due to anonymization
  • Ensure patients can reap the benefits of accessing their own data and learn about their own genomic markers and disease predispositions

Speaker TBC

    • Medical Affairs
    • RWE
Achieve credibility in Real-World Evidence through the assurance of quality data
  • Hold your real-world data to the same standard of quality as RCTs to ensure its credibility
  • Standardize and validate real-world evidence data to establish a usable framework that stakeholders can trust

Speaker TBC

    • RWE
Real-world enrichment of RCT gold standards
  • Leverage RWE as early as possible to complement RCT results for faster access
  • Paint a holistic picture of all your data through the synchronized collection and analysis of real-world data and randomized-controlled trials

Speaker TBC

    • Medical Affairs
    • RWE
Cement RWE’s utility through Medical co-leadership
  • Integrate Medical, Commercial & Outcomes Research team to broaden access of Real-World Evidence to external stakeholders
  • Understand data gaps and how Real-World Evidence can provide a sound scientific platform for data generation for physicians

Sonal Bhatia, Vice President, North America Medical Lead, Rare Diseases, Pfizer

Your future is patient centric

    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • Market Access
    • RWE
    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
Focus on Patient Experience to deliver Patient-Centric Support
  • Put yourself in the shoes of the patient in order to understand unmet needs
  • Analyze patient experience to discover why patients slip through the cracks of PSPs
  • How empathy with the patient set UCB strategy to simplify Patient Access

Peter Stueckemann, Head of Patient Experience & Value, UCB

    • Patient Value
    • Medical Affairs
    • Market Access
    • RWE
Patient Centricity 2.0
  • Move beyond Patient Reported Outcomes to Patient Relevant Outcomes
  • Engage with expert patients to re-think trial design, regulatory, and access plans
  • Unite cross-functional leaders to push traditional scope and discover new patient value

Amy Nicole Nayar, Head of Global Patient Relations, Abbvie

Turn insights into value

    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • Market Access
    • RWE
    • Digital & Customer Experience
    • Patient Value
AI is the pathway to personalized patient support
  • Case Study: How UCB and Georgia Tech are using AI to re-invent patient services
  • Apply Advanced analytics to understand patient needs
  • Segment your patient engagement to successfully match patients to appropriate care quicker

Cynthia Dilley, Head of New Patient Value Focus, UCB

    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • RWE
Panel: Set your patient engagement framework and prove ROI
  • Set a compliant cross-functional strategy to facilitate leveraging patient insights into strategy
  • Champion awareness of patient engagement to embed a culture
  • Empower departments with tools and guidance for self-sufficient patient engagement

Jodie Sherman Gillon, Global Medical Lead, Patient Engagement Rare Diseases, Pfizer

Helena Chung, Patient Engagement Director for Oncology, AstraZeneca

    • Patient Value
    • Medical Affairs
    • Market Access
    • RWE
From Insights to Outcomes: Best-Practices for Patient Centric R&D
  • Best practices for external engagement to integrate patient perspectives
  • Understand how to avoid overlap and translate insights into business process
  • How to align patient recommendations with potentially competing business priorities

Anthony Yanni, Head, Medical Intelligence and Patient Perspectives, Sanofi

    • Patient Value
Panel: Patient-centric models for advocacy and partnerships
  • How under-investing in partnerships models are harming your ROI
  • Why Pfizer launched their Council for Change to redesign external strategy
  • Deliver value to the patient by partnering with advocates to navigate the complexity of patient engagement

Mary Brown, President, CEO, Sickle Cell Disease Foundation of California

Additional panellists TBC

    • Patient Value
Innovate To Engage In Paediatric Care
  • Case Study: Takeda and MIT Media Lab are reimagining PRO collection for pediatric care
  • Design for your audience and tailor gamification strategies to keep patients engaged
  • Why Takeda are open-sourcing their IP once it has received FDA Approval

Magdalena Schoeneich, Global Head, Digital Accelerator, R&D, Takeda

Marketing's data driven future

    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • RWE
    • Digital & Customer Experience
    • Patient Value
What’s unique about User Experience Design within Pharma Marketing?
  • Focus on validated critical customer needs and avoid costly vanity projects that are doomed to fail
  • Sell the value of User-Centered Design to colleagues across commercial
  • Cut the jargon: here’s how we adapt Design Thinking principles into the working culture of pharma

Rahul Avasthy, Digital Transformation Lead, Abbott

    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
The promise of Voice as the next interface and the reality of compliance
  • Voice has created new frontiers for doctors and patients: but how should you engage?
  • Pharma’s role and the implication for sales, marketing and medical
  • How Amazon have partnered with Merck to deliver Patient-Centric Medical communication

Speaker TBC

    • Commercial Excellence
    • Digital & Customer Experience
Who executes in an Omni-Channel era?
  • Craft an operational strategy capable of unlocking the benefits of omnichannel
  • How AI omni-channel strategy will finally deliver relevant customer experience
  • The new model for Sales and Marketing partnership to execute channel strategy

Peter Barschdorff, Vice President, Commercial Insights, GSK

    • Commercial Excellence
    • Digital & Customer Experience
Panel: The new marketing model for data-driven customer-centricity
  • Why marketing must adapt alongside sales in order to deliver omni-channel marketing
  • How to break perverse incentives to align leaderships to change
  • How leaders can manage change to empower employees to transition from execution to strategy

Peter Barschdorff, Vice President, Commercial Insights, GSK

Matthew Smith, Global Strategy Lead, Pfizer

Debra Hussain, Senior Director of Marketing - Multi-Channel Team Leader, Eli Lilly

    • Commercial Excellence
    • Digital & Customer Experience
Avoid One-Size Fits All through intelligent automated campaigns
  • Create an adaptive engagement capability through analytics-driven automation
  • How to pull through customer insights to learn how to engage next
  • Build capacities across teams and country units to scale personalized engagement

Kirk Keaffaber, Senior Marketing Director, Eli Lilly

    • Digital & Customer Experience
Panel: AI-Powered marketing can only move as fast as your content strategy
  • You’ve worked out how to engage, but can you actually execute?
  • How to keep up with demand and build creative partnerships for content
  • Get strategies to adapt and personalize content to deliver relevant engagement

Francois Motyl, Global Digital Governance Lead, Novartis

Debra Hussain, Senior Director of Marketing - Multi-Channel Team Leader, Eli Lilly

    • Digital & Customer Experience
    • Medical Affairs
    • RWE
Adopt Data-Driven Strategy While Protecting Customer Privacy
  • Translate the promise of omni-channel strategy into a roadmap for operational implementation
  • How to manage a holistic customer approach that sets clear boundaries for customer privacy
  • Create structures that scale to spread the benefits of analytics without compromising compliance

Chapman Richardson, Global Head of Data Consumerization, Sanofi

    • Digital & Customer Experience
From internal hubs to acquisition - Best practices for marketing innovation
  • Pharma can’t deliver the omni-channel alone: but what’s the best way forward?
  • How to assess and allocate budget to internal projects
  • When to grow capabilities through external partnerships and acquisition

Emmanuel Fombu, Director, Digital Medicines, Novartis

    • Digital & Customer Experience
Can Marketers ever prove ROI?
  • Shift from basic interaction metrics to a robust approach of assessing impact in marketing investment
  • How to build consensus to agree on comparable ROI metrics for both sales and marketing
  • Develop a framework to assess marketing proposals to maximize the value of marketing budget

Speaker TBC

Customer value

    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
    • Medical Affairs
    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
Partner with Providers to transform Patient Experience
  • Patient Experience requires salesforce to think beyond the product to deliver value
  • Connect and collaborate with your providers to improve patient outcomes
  • Case Study: How AstraZeneca partnered with Geisinger to give Asthma patients mHealth support

Tosh Butt, Vice President, Sales for Primary Care and Respiratory Specialty, AstraZeneca

    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
Performance Comes From Purpose
  • Win top talent and motivate your team by putting patient value first
  • Champion empathy to create genuine partnerships with stakeholders
  • Focus first on value to deliver relevant customer engagement

David Fortanbary, Head of North America Commercial Training, UCB

    • Commercial Excellence
    • Digital & Customer Experience
The role of the rep in a new era of healthcare
  • Help your rep adapt to a new era of value-based care and digital capabilities
  • Set aside silo mentalities within KAMs, MSLs and Reps by incentivizing customer-first action
  • Create a continuous development strategy to motivate and empower your reps to succeed

James Brewer, Director of Global Commercial Operations Marketing Platforms, Eli Lilly

    • Commercial Excellence
    • Digital & Customer Experience
    • Medical Affairs
Panel: Coordinate Your Field Force to Engage With The Customer
  • Hear from the customer: What do they want and what do they actually get?
  • How pharma can change the narrative from product promotion to value creation
  • Tactics to build consensus in both providers and pharma to bring ideas to life

Greg Apostle, National VP, KAM, Alkermes

Stephen Basilotto, Chief Experience Officer, Froedtert Health

Kyle Skiermont, Chief Operating Officer, Fairview Pharmacy Services

Future of Sales

    • Commercial Excellence
    • Digital & Customer Experience
    • Patient Value
    • Market Access
    • Commercial Excellence
    • Digital & Customer Experience
Case Study: Empower Your Salesforce Through Dynamic Targeting
  • No Patient Left Behind: Pharma’s critical role in connecting patients to care
  • Ensure saleforce support the physician at the right place and time with predictive analytics
  • How Shire used dynamic targeting to engage with critically needed disease awareness

Chris Sellin, Head of Operational Excellence & Analytics, Shire

    • Commercial Excellence
    • Digital & Customer Experience
Apply Analytics to Segment Customers and Predict Behavior
  • Understand the must have data, analytics and strategic capabilities for predictive analytics
  • Apply behavioral science to create refined customer segments
  • How the rep turns insights into action through relevant content that boosts conversion
    • Commercial Excellence
    • Digital & Customer Experience
Panel: KPI Paralysis - Why Less is More for Dashboard Design
  • Go beyond ‘one-size fits all’ to strike a compromize that fits your unique needs
  • Eliminate unnecessary KPIs with a relentless focus on the insights that create customer value
  • Compare metrics, analytics and field force actions taken by leadership across industry

Speaker TBC

    • Commercial Excellence
Replicate the success of your top performing reps
  • Set KPIs to establish and track the traits of your top performers
  • Translate success factors into a training plan
  • Scale training to transform your sales team

Speaker TBC

    • Commercial Excellence
Train and develop field force capable of successfully engaging IDNs
  • Overcome ingrained habits to restructure teams around KAM principles
  • Throw away sales incentives and train field force to collaboratively engage to discover value
  • Apply customer-centric principles to take insights through a design process that creates customer solutions

Matt Portch, Vice President, Managed Markets, Sunovion

    • Commercial Excellence
Collaborating with health systems on disease state value
  • Developing a value proposition through research
  • Uncovering information to meet the economic gaps identified through the research
  • The process for transforming insights into solutions and getting IDN decision makers on-board

Drew Suiter, Associate Director, Hospital Systems, Genentech

    • Patient Value
    • Market Access
Panel: The Negative Impact and Financial Burden that Co-pay Accumulators on Patients of Those with no Other Treatment Option
  • Hear about the impact of Co-pay Accumulator Programs to patient’s lives who have no alternative
  • See the PBM perspective to understand their decision-making process
  • Ally with Patient Advocacy groups in the fight against co-pay accumulators

Michelle Rice, Senior Vice President External Affairs, National Hemophilia Foundation

Mike Zeglinski, Senior Vice President, Specialty Pharmacy, OptumRx

    • Keynotes
    • Medical Affairs
Medical Affairs Roundtable Discussions

Select from one of the following topics for a small group discussion with like-minded senior-level executives in an informal setting for 1 hour.

  1. What does effective patient engagement look like for Medical Affairs?
  2. Effective demonstration of Medical Affairs value
  3. A strategic Medical Affairs approach to RWE
  4. Should Medical lead payer negotiations?
  5. How to work with commercial and maintain the trust of stakeholders
    • Keynotes
    • Digital & Customer Experience
Digital & Customer Experience Roundtable Discussions

Select from one of the following topics for a small group discussion with like-minded senior-level executives in an informal setting for 1 hour.

  1. Hype or impact? Test and trial emerging technologies in your marketing channel mix
  2. How can marketers prove relevant ROI to commercial leadership
  3. Breaking Data Silos: How can we align commercial to a common customer view while staying compliant?
  4. How can marketing set strategy for budget, content, decision making to eliminate real-time engagement bottlenecks?
    • Keynotes
    • Market Access
Market Access Roundtable Discussions

Select from one of the following topics for a small group discussion with like-minded senior-level executives in an informal setting for 1 hour.

  1. Are PBMs the biggest problem for drug pricing?
  2. Align on the definition of value across different stakeholders
  3. Innovative pricing mechanisms for gene therapy
  4. Focus on affordability
    • Keynotes
    • RWE
Real-World Evidence Roundtable Discussions

Select from one of the following topics for a small group discussion with like-minded senior-level executives in an informal setting for 1 hour.

  1. The threat of silos to the opportunities big data poses
  2. The application of RWE in risk-sharing models
  3. Should patients own their own data, or give it freely to researchers?
  4. How to achieve a phase 2 launch
  5. Social media as a source of RWE
    • Keynotes
    • Commercial Excellence
Sales & Commercial Excellence Roundtable Discussions

Select from one of the following topics for a small group discussion with like-minded senior-level executives in an informal setting for 1 hour.

  1. Replicate top performers - how do we analyze top performers and reproduce traits through training?
  2. What capabilities do we need in order to apply predictive analytics to sales engagements?
  3. KPI Paralysis - how to build consensus to reduce complexity for cross-functional dashboard design
  4. Creative approaches to access: strategies to co-create with customers and stay relevant
I want to attend I want the Brochure